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1. Introduction 
Bicuspid aortic valve disease is the most common congenital heart defect, affecting 1% to 2% 
of the general population, with a higher prevalence in males (Hoffman & Kaplan, 2002; 
Movahed et al., 2006). Quite often, the diagnosis of bicuspid aortic valve disease is an 
incidental finding during an echocardiogram. However, the disease may be associated with 
significant valvular dysfunction and lead to aortic stenosis (Subramanian et al., 1984; Roberts 
& Ko, 2005) or aortic regurgitation (Roberts et al., 1981; Olson et al., 1984) and is a risk for 
infective endocarditis (Lamas & Eykyn, 2000; Fenoglio et al., 1977). Aortic regurgitation is 
probably more common in younger patients, and aortic stenosis becomes more frequent 
with age (Movahed et al., 2006). In this paper we reviewed the current literature on bicuspid 
aortic valve disease, particularly its etiopathogenesis, and report a case-control investigation 
of the relationship between this disease and coronary heart disease. 
1.1 History 
The earliest description of a bicuspid aortic valve has been attributed to Leonardo da Vinci, 
who over 400 years ago sketched the bicuspid variant of the aortic valve (Mills et al., 1978, as 
cited in Braverman et al., 2005). In 1844, Paget brought attention to the propensity of the 
bicuspid aortic valve to develop disease, and in 1858, Peacock reported the tendency of 
these valves to develop obstructive lesions initially, with subsequent incompetence (Roberts, 
1970, as cited in Braverman et al., 2005). The clinical significance of the bicuspid aortic valve 
was also emphasized by Osler in 1886 when he described 18 cases of bicuspid aortic valve 
with the predilection of these valves to develop infective endocarditis (Wauchope, 1928, as 
cited in Braverman et al., 2005). In the 1950s, investigators observed that the propensity to 
develop isolated calcific aortic stenosis occurring in the setting of bicuspid aortic valve was 
the result of an intrinsic property of the bicuspid aortic valve rather than the result of 
rheumatic disease (Campbell et al., 1953, Smith & Matthews, 1955, and Bacon & Matthews, 
1959, as cited in Braverman et al., 2005). Wauchhope’s autopsy studies established that the 
bicuspid aortic valve is the commonest congenital anomaly of the heart (Mills et al., 1978 
and Wauchope, 1928, as cited in Braverman et al., 2005). Furthermore, the association of 
bicuspid aortic valve with diseases of aorta was first commented on by Abbott in 1927 with 
the description of an association between congenital bicuspid aortic valve with aortic 
dissection (Acierno, 1994, as cited in Braverman et al., 2005). 
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1.2 Morphogenesis of bicuspid aortic valve 
Bicuspid aortic valve likely results from a complex developmental process, not simply the 
fusion of two normal cusps (Sans-Coma et al., 1996). However, the exact mechanism 
remains unclear. Some researchers have implicated the anomalous behaviour of cells 
derived from the neural crest as a possible etiology (Kappetein et al., 1991; Fernández et al., 
1998; Mancuso et al., 2002). The proponents of this theory note that bicuspid aortic valve is 
associated with congenital malformations of the aortic arch and other neural crest derived 
systems (Duran et al., 1995; Kappetein et al., 1991). In particular, some researchers suggest 
that a molecular abnormality in the extracellular matrix may lead to abnormal 
valvulogenesis, becouse matrix proteins help direct cell differentiation and cusp formation 
during valvulogenesis (Hinton et al., 2006; Eisenberg & Markwald, 1995; Fedak et al., 2002). 
This could also explain why bicuspid aortic valve is often linked to other cardiovascular 
anomalies, which will be mentioned below (Duran et al., 1995). In an another study Lee et al. 
(2000) reported that mice lacking endothelial nitric oxide synthase had a predisposition to 
forming bicuspid aortic valve, which suggests that abnormalities in this protein may lead to 
the disruption of intricate cell signals required for proper valvulogenesis in the mammalian 
heart. In human development, organogenesis is completed during the first trimester of 
pregnancy, after which further maturation and growth predominate. The first organ to form 
is the heart, with the earliest recognizable cardiac structure evident on day 15 of gestation, 
when the cardiac progenitor cells have been specified and are organized in a crescent shape. 
At three weeks of gestation, these bilaterally symmetric heart primordial cells migrate to the 
midline and fuse to form a single linear heart tube with an inner endothelial lining 
surrounded by an outer myocardial cell layer, which are separated by extracellular matrix. 
During the sixth and seventh weeks of gestation, the heart divides into four distinct 
chambers and an aorta and pulmonary artery, respectively, resulting in separated 
pulmonary and systemic circulations (Rabkin-Aikawa al., 2004; van den Hoff et al., 1999). 
The process of valvular morphogenesis begins from the time at which the heart is a simple 
tube. The initial endocardial cushions, which will contribute to all four cardiac valves, are 
formed by the thickening of the extracellular matrix in the region of the atrioventricular and 
outflow tract. Within the next day, there is a complex interplay of myocardial and 
endocardial signaling, which is necessary for proper endothelial-to-mesenchymal 
transformation. This process is initiated by the secretion of extracellular matrix proteins 
such as fibronectin and transferrin across the cardiac jelly to the adjacent endocardium. The 
endocardium then secretes transforming growth factor beta family members, which act 
synergistically with bone morphogenetic protein-2 secreted by the myocardium, to increase 
mesenchyme formation and proliferation, which results in the growth of the endothelial 
cushions. The myocardial cells then invade the margins of the cellular endothelial cushions. 
In the outflow tract, the truncal cushion swellings contribute to form three leaflet valves of 
the aorta and pulmonary artery. When this process is distrupted in the aorta, the primordial 
leaflets do not separate or remain fused, which results in bicuspid aortic valve (reviewed in 
De Mozzi et al., 2008). 
1.3 Genetics 
Although most cases of bicuspid aortic valve disease are sporadic, familial clusters have 
been identified (Emmanuel et al., 1978; Glick & Roberts, 1994; Hungtington et al., 1997). The 
earliest studies suggesting that bicuspid aortic valve disease was the consequence of an 
underlying genetic abnormality were case reports describing familial clustering of bicuspid 
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aortic valve disease and reports of bicuspid aortic valve disease in monozygotic twins 
(McKusick, 1972; Gale et al., 1977; Godden et al., 1987; McDonald & Maureer, 1989; Brown et 
al., 2003). Subsequently, other authors sought to evaluate the relatives of patients with 
bicuspid aortic valve disease to investigate the prevalence of bicuspid aortic valve disease in 
the family members of affected patients. Emmanuel et al. (1978) studied 41 families with a 
member having surgically proven bicuspid aortic valve disease. Six of the families had more 
than one affected member. Of note, the diagnosis of bicuspid aortic valve disease in this 
study was based largely on the findings of the clinical examination, chest radiograph, and 
electrocardiogram; only a limited number were examined using M-mode echocardiography 
(Emmanuel et al., 1978). In contrast, Glick and Roberts (1994) studied the genetics of six 
families in whom greater than one member had aortic valve disease; 11 members had 
bicuspid aortic valve disease confirmed during surgery. They noted that of the 71 family 
members investigated, 17 (24%) had evidence of aortic valve disease likely secondary to a 
bicuspid aortic valve. In a prospective study, Hungtington et al (1997) assessed the 
frequency of familial clustering of congenital bicuspid aortic valve using two-dimensional 
echocardiography. They identified 39 consecutive patients with bicuspid aortic valve 
disease in their database and attempted to enroll 210 first-degree relatives. They were able to 
obtain echocardiographic evaluations in 89% of the first-degree relatives and reported that 
9% of the relatives had a definitive diagnosis of bicuspid aortic valve. This was a 
significantly higher prevalence than the 1% prevalence that has generally been described in 
the literature for the general population. However, given the asymmetric clustering of a 
number of cases in some of the families, the inheritance pattern in those families was felt to 
be more compatible with an autosomal-dominant inheritance pattern with reduced 
penetrance (Hungtington et al., 1997). 
Other studies have suggested multiple complex modes of inheritance for bicuspid aortic 
valve disease. Statistical genetic models have been tested to demonstrate that the regions of 
the genome are responsible for the phenotype of bicuspid aortic valve. However, to date, 
only a few studies have identified responsible genomic regions. Interestingly, some of the 
genes identified appear to account for inheritance in only a small proportion of the familial 
cases of bicuspid aortic valve disease reported. One of these genes identified is NOTCH1. 
Analyses of mouse and zebrafish Notch mutants revealed an essential role for NOTCH1 in 
promoting the epithelial-to-mesenchymal transition process (Timmerman et al., 2004). 
During the development of aortic valve in mice, NOTCH1, is highly expressed and represses 
the activity of a central transcriptional regulator of osteoblast cell fate (reviewed in 
Artavanis-Tsakonas et al., 1999). In 2005, Garg et al. (2005) identified a five-generation 
European-American family showing linkage for bicuspid aortic valve to a single locus on 
chromosome 9q34-35. Direct sequencing of all coding exons of the NOTCH1 gene revealed a 
heterozygous C-to-T transition of nucleotide 3322 leading to a premature stop codon at 
position 1108 (p.R1108X). Additionally, in a second and smaller Hispanic family, a second 
mutation (p.H1505del) in NOTCH1 co-segregated with the disease in three affected family 
members. None of these mutations could be found in the 1138 controls. The authors 
suggested that mutations of the NOTCH1 gene may have caused an early developmental 
defect in the aortic valve and later led to a de-repression of calcium deposition and an aortic 
valve disease.  
Other genes identified in bicuspid aortic valve disease are the potassium channel gene 
KCNJ2 (chromosome 17q24.3) (Andelfinger et al., 2002) and the ubiquitin fusion degradation 
1–like gene UFD1L (chromosome 22q11.2) (Mohamed et al., 2005). The UFD1L gene encodes 
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a component of a multi-enzyme complex involved in the degradation of ubiquitin fusion 
proteins, and is highly expressed during embryogenesis in certain tissues. It seems to play a 
key role in the development of ectoderm-derived structures, including neural crest cells. 
Downregulation of the UFD1L gene, hypothetically resulting from an anomalous behavior 
of neural crest cells, may lead to reduced degradation activities, and may finally lead to 
fusion of valve cushions, a key factor in the development of congenital bicuspid aortic valve 
(Yamagishi et al., 2003). The presence of multiple genomic regions associated with bicuspid 
aortic valve disease demonstrates genetic heterogeneity and further supports complex 
inheritance. Given that a large proportion of bicuspid aortic valve disease familial cases are 
of unknown etiology, it is expected that other regions of the genome also predispose 
individuals to develop bicuspid aortic valve or associated cardiovascular malformations. 
Martin et al. (2007) have recently identified some regions of the human genome that harbor 
genes influencing the inheritance of bicuspid aortic valve disease or associated 
cardiovascular malformations. In particular, three novel loci for bicuspid aortic valve and 
associated cardiovascular malformations were identified on chromosomes 18, 5, and 13.  
1.4 Bicuspid aortic valve anatomy, variants, and pathologic features 
An intraoperative appearance of bicuspid aortic valve is shown in Figure 1. The anatomy of 
the bicuspid aortic valve usually includes unequal cusp size (due to fusion of two cusps 
leading to one larger cusp), the presence of a central raphe (usually in the center of the 
larger of the two cusps), and smooth cusp margins. The leaflets are usually oriented right to 
left, with the true commissures oriented anterior and posterior. Three morphologies are 
identified: type 1, fusion of right coronary cusp and left coronary cusp; type 2, fusion of 
 
 
Fig. 1. An intraoperative appearance of bicuspid aortic valve 
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right coronary cusp and noncoronary cusp; and type 3, fusion of left coronary cusp and 
noncoronary cusp (Schaefer, 2008; Sievers & Schmidtke, 2007). The most common is type 1 
(70% to 86%), followed by type 2 (12% to 28%) and type 3 (1% to 3%) (Fernandes et al., 2004; 
Sabet et al., 1999). The raphe or fibrous ridge is the site of congenital fusion of the two 
components of the conjoined cusps and is identifiable in most bicuspid aortic valve patients 
(Sabet et al., 1999). Of interest, pathologic examination of the raphe has shown that it does 
not contain valve tissue (Pomerance, 1972). Sometimes it shows a deep indentation, which 
gives a false image of a tricuspid valve on two-dimensional echocardiography. Valvular 
incompetence is usually caused by the redundancy of one cusp, since the two cusps usually 
have different dimensions (reviewed in De Mozzi et al., 2008). Few cases of congenital 
bicuspid aortic valve are accompanied by an abnormal fibrous band stretched from the 
center of the conjoined cusp to the aortic wall, and they appear to be associated with valve 
insufficiency (Nakamura et al., 1999). 
1.5 The bicuspid aortic valve and associated congenital or acquired cardiovascular 
lesions 
Despite its importance, our understanding of bicuspid aortic valve disease is incomplete, 
and questions remain unanswered about this common condition. Although much of the 
original focus centered on the abnormal bileaflet valve, the disease is significantly more 
complex. Bicuspid aortic valve disease is not only a disorder of valvulogenesis, but also 
represents the coexistent aspect of a genetic disorder of aorta or cardiac development. 
Accordingly, associated congenital cardiovascular anomalies have been reported in as many 
as 25% of patients. Patent ductus arteriosus and ventricular septal defect are the most 
frequent heart defects associated with bicuspid aortic valve disease (Deshpande & Kinare, 
1991; Suzuki et al., 1994). Hypoplastic left heart syndrome, complete atrioventricular canal 
defect, Ebstein’s anomaly, and partial or total anomalous pulmonary venous return. 
Tetralogy of Fallot, double-outlet right ventricle (Fernandes, et al., 2004), Williams 
syndrome (Lopez-Rangel et al., 1992), and Down syndrome (Weinhouse et al., 1995) are 
occasionally associated with bicuspid aortic valve disease. Shone’s complex, which is 
defined by four cardiovascular defects (supravalvular mitral membrane, valvular mitral 
stenosis with a parachute mitral valve, subaortic stenosis, and aortic coarctation), is rare and 
forms another association in bicuspid aortic valve disease cases (Popescu et al., 2008). 
Moreover, many vascular abnormalities, such as aortic dilatation (Sabet et al., 1999; Ward, 
2000; Fedak et al., 2002; Bauer et al., 2002; Alegret et al., 2003), aortic aneurysm (Sabet et al., 
1999; Ward, 2000; Fedak et al., 2002; Bauer et al., 2002; Alegret et al., 2003), aortic dissection 
(Larson & Edwards, 1984; Ward, 2000; Fedak et al., 2002), coarctation of the aorta (Ward, 
2000; Lindsay, 1988; Warnes, 2003), interrupted aortic arch (Roberts et al., 1962), 
cervicocephalic arterial dissection (Schievink & Mokri, 1995), ductus diverticulum aneurysm 
(Sagic et al., 1997), and annuloaortic ectasia (Oyonarte et al., 1992) have been described in 
association with bicuspid aortic valve disease. Aortic dilatation, with an estimated 
prevalence of approximately 50%, is the most common abnormality among these vascular 
abnormalities that have been reported in association with bicuspid aortic valve disease 
(Pachulski et al., 1991 Hahn et al., 1992; Fedak et al., 2002; Alegret et al., 2003). 
1.6 The bicuspid aortic valve and associated disorders in coronary arteries 
Besides these abnormalities involving different arteries, some reports have also suggested 
the involvement of coronary arteries, including congenital coronary artery anomalies 
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(Rashid et al., 2005; Palomo et al., 1985; Doty, 2001), coronary artery fistulas (Oomman & 
Mao, 2000), spontaneous coronary artery dissection (Labombarda et al., 2009), reversal of 
coronary dominance (Hutchins et al., 1978; Higgins & Wexler, 1975), and immediate 
bifurcation and a shorter length of the left main coronary artery (Hutchins et al., 1978; 
Higgins & Wexler, 1975; Yuan et al., 2010). 
There have also been some case reports describing patients with bicuspid aortic valve 
disease associated with coronary heart disease (Shimuzu et al., 1984; Bensaid et al., 1978; 
Yokoyama et al., 2002; Theleman et al., 2006) and even with acute myocardial infarction 
(Demir, 2009). There are also some studies in which the prevalence rate of angiographic 
coronary heart disease among the patients with bicuspid aortic valve disease has been given 
(Yuan et al., 2010; Goland et al., 2007). However, to the best of our knowledge, there is only 
one study in the current literature comparing the prevalence rate of angiographic coronary 
heart disease between patients with and without bicuspid aortic valve disease (Yuan et al., 
2010). However, that study was retrospective in nature and was not designed primarily to 
compare the prevalence rate of angiographic coronary heart disease in bicuspid aortic valve 
disease patients with the rate in an age- and gender-matched control group. 
On the other hand, it has been suggested that from 15% to 50% of patients with coronary 
heart disease lack any of the four conventional risk factors for this disease (i.e., 
hypercholesterolemia, hypertension, diabetes mellitus, and cigarette smoking) (Hennekens, 
1998; Futterman & Lemberg, 1998; Khot et al., 2003; Greenland et al., 2003). Atherosclerosis 
is a complex disease process resulting from the interaction of a number of environmental 
and genetic factors. Evidence from epidemiologic studies has consistently demonstrated that 
there is a substantial heritable component to atherosclerosis susceptibility (Hunt et al., 2002; 
Fox et al., 2003). 
1.7 Aim of the study 
Based on the above-mentioned knowledge, in the present study, we aimed to determine 
whether or not there is a relationship between the presence of bicuspid aortic valve disease 
and the occurrence, severity, and extent of angiographic coronary heart disease. We also 
sought to determine whether the relationship, if any, between bicuspid aortic valve disease 
and coronary heart disease is due to the changes in flow dynamics secondary to stenosis or  
regurgitation in the aortic valve. We also sought to determine any possible relationship 
between the type of bicuspid aortic valve and occurrence of coronary heart disease. 
2. Material and methods 
2.1 Study design 
Over a 9-year period, 11,702 consecutive patients who underwent coronary angiography at 
our institution for the first time for suspected coronary heart disease (mainly for the 
evaluation of typical, atypical, or non-anginal chest pain or electrocardiogram findings 
suggesting the disease) were subjected to routine transthoracic Doppler echocardiography 
to detect bicuspid aortic valve disease. Based on echocardiographic examinations, a 
diagnosis of bicuspid aortic valve disease was made in 115 (0.98%) of the patients (bicuspid 
aortic valve disease group). From the same population and during the same period, for each 
case patient, we randomly selected a control from the patients who had no bicuspid aortic 
valve disease, age- (within 1 year) and gender-matched to the case patient (control group,  
n = 115). For the purposes of the study, from the coronary angiograms, we determined the 
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prevalence rate of coronary heart disease and the scores derived using three different 
scoring systems, which reflect severity and extent of the disease, in the bicuspid aortic valve 
disease group and control group, and we compared these variables between these two 
groups. 
The median number of diseased vessels, the distribution of the coronary arteries disease, 
and conventional risk factors for coronary heart disease (hypercholesterolemia, hypertension, 
diabetes mellitus, cigarette smoking, and family history for premature coronary heart 
disease), the frequency of patients with an associated congenital coronary artery anomaly 
and with a comorbid condition, median of length of the left main coronary artery, and the 
frequency of coronary artery dominance patterns were also determined and compared 
between the groups. 
To determine whether bicuspid aortic valve disease is an independent risk factor for 
coronary heart disease, we also conducted a multivariate logistic regression analysis with 
coronary heart disease as the dependent variable, and with age, gender, hypercholesterolemia, 
diabetes, smoking, family history for premature coronary heart disease, and bicuspid aortic 
valve disease as independent variables. We also compared the prevalence rates of the four 
conventional risk factors for coronary heart disease and the prevalence rate of the patients 
without any of these risk factors between patient groups, which consisted of patients in the 
total study population with and without angiographic coronary heart disease. 
Furthermore, to determine whether the association, if any, between bicuspid aortic valve 
disease and coronary heart disease was due to functional alterations in the aortic valve, we 
first determined the presence and severity of aortic stenosis and aortic regurgitation and the 
presence of aortic dilatation in the bicuspid aortic valve disease group, and then compared 
the frequency of patients with moderate or severe aortic stenosis, moderate or severe aortic 
regurgitation, moderate or severe aortic stenosis or regurgitation, and aortic dilatation 
between coronary heart disease-present and coronary heart disease-absent subgroups of this 
group. 
Finally, to determine whether there is a relationship between the type of the bicuspid aortic 
valve and occurrence of coronary heart disease, we compared the prevalence rates of 
coronary heart disease within each of the three subgroups, which were divided according to 
the type of the bicuspid aortic valve in the bicuspid aortic valve disease group. 
2.2 Angiographic measurements 
All patients underwent coronary angiography, using standard techniques. Angiograms 
were assessed independently by two experienced interventional cardiologists (M.N.A., A.C.) 
who were blinded to the patients’ clinical parameters. Coronary heart disease was defined 
as the presence of angiographic coronary stenosis greater than or equal to 50% of the 
luminal diameter in at least one of the three major epicardial arteries or in a major branch on 
quantitative coronary analysis. The patients with no irregularities or with minor 
irregularities of the coronary vasculature, or with a moderate diameter reduction less than 
50%, were classified as without coronary heart disease. 
All coronary angiographies classified as coronary heart disease were assessed using the 
modified Gensini index as previously described (Gensini, 1983; Ringqvist et al., 1983). 
Briefly, location, degree of stenosis (severity), and number of occluded segments (extent) 
were evaluated. Coronary vasculature was divided into 27 coronary segments, and each 
involved segment was weighted by a value from 0.5 (least important) to 5.0 (critical 
location), reflecting the location of coronary artery lesions. The severity (percentage of 
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stenosis) was weighted as follows: < 25%, 2; 26–50%, 4; 51–75%, 8; 76–90%, 16; 91–99%, 32; 
100%, 64. Extent was determined by the number of occluded segments (from 1 to 27) and 
constitutes score III. Score II is the sum of the weighted severity for all involved segments. 
The product of the weights for location and severity is the total weight for each arterial 
segment, and the sum of all segments involved constitutes score I (the modified Gensini 
index), reflecting location, severity and extent (Ringqvist et al., 1983). The length of the left 
main coronary artery was measured on the right anterior oblique view of the archived 
coronary angiography images. 
2.3 Echocardiographic measurements 
Comprehensive two-dimensional and Doppler echocardiographic examinations were 
performed in a systemic manner by experienced cardiologists who were blinded to the 
study. In addition to the other routine examinations, aortic valve morphology and function, 
as well as aortic arterial dimensions were determined. Aortic valve morphology was 
assessed in the parasternal long- as well as short-axis views. The diagnosis of bicuspid aortic 
valve was based on previously defined criteria (Brandenburg et al., 1983) as the presence of 
only two cusps was clearly identified in systole and diastole in the short-axis view. Patients 
with fusion of the commissures attributable to rheumatic disease (Rose, 1986; Passik et al., 
1987) were not included as having bicuspid aortic valve. An example for the 
echocardiograms of our patients with bicuspid aortic valve is shown in Figure 2. In this 
transthoracic two-dimensional echocardiogram in parasternal short-axis view at the aortic 
valve level, a clear systolic ‘’fish-mouth’’ appearance of the aortic valve in mid-systole 
(arrow) is seen. The type of bicuspid aortic valve was determined from the short-axis view 
of transthoracic echocardiograms as previously described (Schaefer et al., 2008). Three 
morphologies, namely, type 1 (fusion of right and left coronary cusps), type 2 (fusion of 
right and noncoronary cusps), and type 3 (fusion of left and noncoronary cusps), were 
identified based on orientation of the valve cusps. 
Aortic regurgitation was evaluated by color Doppler in the parasternal long-axis and short-
axis views, and in the apical long-axis and five-chamber views. The severity of aortic 
regurgitation was assessed by the ratio of proximal jet area to left ventricular outflow tract 
area in combination with the ratio of jet height to left ventricular outflow tract height. In 
addition, the rate of deceleration of the velocity signal of aortic regurgitation and the 
presence of retrograde flow in the abdominal aorta on continuous-wave Doppler 
echocardiography were also considered in our assessment. These combined indices were 
analyzed to grade aortic regurgitation as mild, moderate, or severe, according to the 
American Society of Echocardiography criteria (Zoghbi et al., 2003). 
Aortic stenosis was evaluated by both pulsed-wave and continuous-wave Doppler. Aortic 
stenosis was defined as present when the aortic peak velocity obtained by continuous-wave 
Doppler was > 2.5 m/s, and was classified as mild (valve area > 1.5 cm2; mean pressure 
gradient < 25 mmHg), moderate (valve area, 1.0-1.5 cm2; mean pressure gradient = 25-40 
mmHg), or severe (valve area < 1.0 cm2; mean pressure gradient > 40 mmHg) (Bonow et al., 
2006). Figure 3 shows an example of the continuous wave Doppler images of severe aortic 
stenosis and mild aortic regurgitation in a patient with bicuspid aortic valve disease. 
Thoracic aortic diameter measurements were taken in the parasternal long-axis view at the 
end of diastole at the level of the aortic annulus, sinus of Valsalva, sinotubular junction, and 
proximal ascending aorta (measured 1 cm from the sinotubular junction), as previously 
described (Roman et al., 1989). Measurements were made perpendicular to the long axis of 
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the aorta using the leading-edge-to-edge method in views showing the largest aortic 
dimensions. The average of two measurements taken at every level was recorded. A dilated 
aorta was defined as an ascending aorta with a diameter greater than 37 mm, which is near 
the 95th percentile for this region for gender and body surface area (Roman et al., 1989; 
Vasan et al., 1995). 
 
 
Fig. 2. Transthoracic two-dimensional echocardiogram in parasternal short-axis view of the 
aortic valve in mid-systole showing a clear systolic ‘’fish-mouth’’ appearance of the bicuspid 
aortic valve orifice (arrow) 
2.4 Other definitions 
The five conventional risk factors for coronary heart disease were defined as follows: 
hypercholesterolemia: having a serum total cholesterol level of greater than or equal to 200 
mg/dL, or an LDL-cholesterol level of greater than or equal to 130 mg/dL, or current 
treatment with lipid-lowering agents; hypertension: having an average blood pressure of 
greater than or equal to 140 mmHg systolic or 90 mmHg diastolic on three different 
occasions, or using antihypertensive medication; diabetes mellitus: having a fasting serum 
glucose of greater than or equal to 126 mg/dL (if confirmed on a subsequent day) or a 2-
hour post load glucose of greater than or equal to 200 mg/dL, or using antidiabetic 
medication; family history of premature coronary heart disease: having a history of 
coronary heart disease in a first-degree male relative less than 55 years old or in a female 
first-degree relative less than 65 years old; and cigarette smoking: smoking more than or 
equal to 5 cigarettes per day for at least one year. 
2.5 Exclusion criteria 
Patients with a history or evidence of current or previous acute coronary syndrome, or with 
a history of percutaneous coronary intervention or coronary artery bypass grafting were 
excluded from the study. 
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The study protocol was approved by the Institutional Ethics Committee, and written 
informed consent was obtained from all study participants. 
 
 
Fig. 3. Continuous wave Doppler recording of a bicuspid aortic valve (from apical five-
chamber approach) showing severe stenosis across the valve and mild regurgitation 
2.6 Statistical analyses 
Statistical calculations were done using SPSS 17 (SPSS Inc., Chicago, IL, USA). Before the 
comparisons between the groups, the continuous variables were tested for normality using 
the Kolmogorov-Smirnov test. Data are expressed as mean ± standard deviation for 
normally distributed continuous variables, as median (25th, 75th percentile) for non-normally 
distributed continuous variables, and as numbers and percentages [n (%)] for categorical 
variables. All tests were two-sided, and alpha was set at = 0.05. For comparisons, Student’s 
t-test was used for normally distributed data, and the Mann–Whitney U-test was used for 
data that was non-normally distributed. A χ2 test with Yates’s correction or Fisher’s exact 
test was used for categorical data. 
3. Results 
3.1 Study population 
As seen in Table 1, the bicuspid aortic valve disease group and control group were not 
significantly different in age, gender, the frequency of the indications for coronary 
angiography (i.e., presence or absence of typical, atypical, or non-anginal chest pain), 
conventional risk factors for coronary heart disease, the presence of an associated congenital 
cardiovascular anomaly, or comorbidity status. 
www.intechopen.com
A Case-Control Investigation of the Relationship Between  
Bicuspid Aortic Valve Disease and Coronary Heart Disease 
 
301 
Bicuspid Aortic Valve 
Disease Group (n = 115) 
Control Group 
(n = 115) 
 
p 
  Age (years) 56.4 ± 13.8 56.4 ± 13.6 N.S. 
  Gender (male) 96 (83.5) 96 (83.5) N.S. 
Indications for angiography    
  Typical chest pain 71 (61.7) 67 (58.3) N.S. 
  Atypical or non-anginal chest pain 34 (29.6) 36 (31.3) N.S. 
  No chest pain 10 (8.7) 12 (10.4) N.S. 
Conventional risk factors for coronary 
heart disease  
   
  Hypertension 25 (21.7) 20 (17.4) N.S. 
  Diabetes 7 (6.1) 8 (7.0) N.S. 
  Ever smoker 27 (23.5) 30 (26.3) N.S. 
  Hypercholesterolemia  20 (17.4) 15 (13.0) N.S. 
  Family history of premature coronary  
  heart disease 
 
6 (5.2) 
 
7 (6.1) 
 
N.S. 
  Associated congenital cardiovascular 
  anomaly present 
 
31 (2.6) 
 
0 (0.0) 
 
N.S. 
Comorbidity    
  Atrial fibrillation 5 (3.8) 2 (1.7) N.S. 
  Renal failure 2 (1.7) 1 (0.9) N.S. 
  Hypothyroidism 1 (0.9) 1 (0.9) N.S. 
  Hyperthyroidism 0 (0.0) 1 (0.0) N.S. 
  Marfan’s syndrome 1 (0.9) 0 (0.0) N.S. 
  Iron deficiency anaemia 1 (0.9) 1 (0.9) N.S.  
1Coarctation of the aorta in 1, secundum type atrial septal defect in 1, and operated patent ductus 
arteriosus in 1 case. 
Table 1. Baseline characteristics of the groups. N.S.: Not significant 
 
  
Number and percentage of patients 
a) Functional alterations of the aortic valve  
Aortic regurgitation 38 (33.0) 
Severe  10 (8.7) 
Moderate 15 (13.0) 
Mild 13 (11.3) 
Aortic stenosis 32 (27.8) 
Severe  9 (7.8) 
Moderate 13 (11.3) 
Mild 10 (8.7) 
Combined aortic stenosis and regurgitation 28 (24.4) 
Severe or moderate stenosis 10 (8.7) 
Severe or moderate regurgitation 10 (8.7) 
Severe or moderate stenosis and regurgitation 4 (3.5) 
Mild stenosis and regurgitation 4 (3.5) 
No functional abnormalities 17 (14.8) 
b) Aortic dilatation  47 (40.9) 
Table 2. Functional alterations of the aortic valve and prevalence of aortic dilatation in 115 
patients with bicuspid aortic valve disease 
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In the bicuspid aortic valve disease group, data on the type of the bicuspid aortic valve were 
not available in 25 (21.7%) patients. Among the remaining 90 patients, the most common 
morphology of the bicuspid aortic valve was type 1 (n = 70 [77.8%]), followed by type 2  
(n = 18 [%20.0]) and type 3 (2 [2.2%]). Among the 115 patients with bicuspid aortic valve 
disease, the bicuspid aortic valve was regurgitant in 38 (33.0%) patients, stenotic in 32 
(27.8%) patients, combined regurgitant and stenotic in 28 (24.4%) patients, and functionally 
normal in 17 (14.8%) patients, and aortic dilatation was present in 47 (40.9%) patients (Table 2). 
3.2 Angiographic results 
Coronary angiography revealed a significantly higher incidence of coronary heart disease in 
the bicuspid aortic valve disease group than in the control group (73.9% vs. 60.0%; p = 0.035). 
The median (25th; 75th percentile) number of diseased vessels (2.0 [2.0; 2.0] vs. 2.0 [1.0; 2.0]; 
p = 0.021) and indices of severity (score II, 99.0 [77.0; 122.0] vs. 88 [77.0; 111.0]; p = 0.029) and 
extent (score III, 10.9 [7.8; 12.55] vs. 8.9 [6.7; 11.65]; p = 0.026), and the modified Gensini 
index (score I, 106.0 [84.0; 129.0] vs. 95.0 [84.0; 118.0]; p = 0.016), which reflects location, 
severity, and extent, were also significantly higher in the bicuspid aortic valve disease group 
than in the control group (Table 3). Additionally, the median (25th; 75th percentile) length of  
 
 
 
Bicuspid Aortic Valve
Disease Group 
(n = 115) 
Control Group 
(n = 115) 
 
p 
Coronary heart disease on angiogram 85 (73.9) 69 (60.0) 0.035 
No of diseased vessels 2.0 (2.0; 2.0) 2.0 (1.0; 2.0) 0.021 
Indexes of severity and extent of 
coronary heart disease 
   
 Score I (location/severity/extent) 106.0 (84.0;129.0) 95.0 (84.0;118.0) 0.016 
 Score II (severity) 99.0 (77.0;122.0) 88.0 (77.0;111.0) 0.029 
 Score III (extent) 10.9 (7.8;12.55) 8.9 (6.7;11.65) 0.026 
1-vessel disease 11 (12.9) 18 (26.1) 0.062 
Multi-vessels disease 74 (87.1) 51 (73.9) 0.062 
Left main coronary artery 3 (1.7) 1 (0.8) 0.641 
Left anterior descending artery 81 (46.8) 61 (48.4) 0.877 
Circumflex artery 31 (17.9) 32 (25.4) 0.155 
Right coronary artery 58 (33.5) 32 (25.4) 0.166 
Length of the  
left main coronary artery, mm 
 
7.7 (6.0;9.0) 
 
8.9 (4.7;9.7) 
 
0.019 
Coronary artery anomaly  212.4) 12 (1.5) 1.000 
Coronary dominance patterns    
 Dominant right coronary artery 90 (78.3) 103 (89,6) 0.031 
 Dominant circumflex artery 22 (19.1) 10 (8.7) 0.036 
 Co-dominant arteries  
(right coronary artery, circumflex artery)
 
3 (2.6) 
 
2 (1.7) 
 
0.645 
1Split right coronary artery in one patient and a fistula from the right coronary artery to the right 
ventricle in the other one patient. 
2Circumflex artery arising from the proximal right coronary artery. 
Table 3. Coronary angiographic findings in the groups 
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the left main coronary artery was significantly shorter (7.7 [6.0; 9.0] vs. 8.9 [4.7; 9.7]; p = 0.019) 
and the prevalence of left dominance (19.1% vs. 8.7%, p = 0.036) was significantly higher in 
the bicuspid aortic valve disease group than in the control group than in the control group 
(Table 3). Furthermore, although the difference was not significant, the test showed a higher 
frequency of multi-vessel disease in the bicuspid aortic valve disease group than in the 
control group (87.1% vs. 73.9%; p = 0.062). There were no significant differences between the 
two groups with regard to the distribution of the diseased coronary arteries (Table 3). 
3.3 Results of the logistic regression analysis 
The results of the logistic regression analysis are presented in Table 4. This analysis revealed 
that together with age (Odds ratio: 1.03; 95% confidence interval: 1.002-.048; p = 0.031), the 
presence of bicuspid aortic valve disease (Odds ratio: 1.90; 95% confidence interval:  
1.070-3.357; p = 0.028) was an independent risk factor for coronary heart disease. In this 
analysis, none of the other independent variables, namely, gender, hypercholesterolemia, 
diabetes, smoking, and family history for premature coronary heart disease, was significant. 
 
 Odds ratio 95% Confidence intervals p 
Age 1.03 1.00-1.05 0.019 
Male gender 0.81 0.37-1.75 N.S. 
Hypercholesterolemia 1.24 0.54-2.83 N.S. 
Hypertension 1.42 0.63-3.18 N.S. 
Diabetes 1.94 0.57-6.59 N.S. 
Smoking 1.02 0.508-2.029 N.S. 
Family history for premature 
coronary heart disease 
 
0.92 
 
0.27-3.09 
 
N.S. 
Bicuspid aortic valve disease 1.90 1.07-3.37 0.028 
Table 4. Results of the multivariable logistic regression for the presence of angiographically 
proven coronary heart disease. N.S.: Not significant 
3.4 Comparison of the demographic data and the frequency of patients with a risk 
factor for coronary heart disease and those without any of these factors between the 
coronary heart disease-present and -absent groups in the total study population 
The mean age was significantly higher and the prevalence of patients without any of the 
four risk factors for coronary heart disease were significantly lower the coronary heart 
disease-present group than in the coronary heart disease-absent group. However, none of 
the four risk factors for coronary heart disease were significantly different between the 
groups, although there was  a trend toward a higher prevalence of hypertension, diabetes, 
and hypercholesterolemia in the coronary heart disease-present group (Table 5). 
3.5 Relationship between the functional alterations in aortic valve and aortic dilatation 
and the presence of coronary heart disease in the bicuspid aortic valve disease group 
No significant changes were detected between the coronary heart disease-present and 
coronary heart disease-absent subgroups of the bicuspid aortic valve disease group with 
respect to the frequency of patients with moderate or severe aortic stenosis, moderate or 
severe aortic regurgitation, moderate or severe aortic stenosis or aortic regurgitation, and 
aortic dilatation, although all of these variables tended to be higher in the former than the 
latter subgroup (Table 6). 
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 Coronary Heart Disease  
 Present (n = 154) Absent (n = 76) p 
Age 57.9 ± 13.7 53.2 ± 13.2 0.014 
Gender (male) 128 (83.1) 64 (84.2) 0.983 
Hypertension 34 (22.1) 11 (14.5) 0.234 
Diabetes 11 (7.1) 4 (5.3) 0.795 
Ever smoker 38 (24.7) 19 (25.0) 1.000 
Hypercholesterolemia 25 (16.2) 10 (13.2) 0.678 
Family history for  
premature coronary heart disease 
 
8 (5.2) 
 
5 (6.6) 
 
0.901 
Absence of these risk factors  50 (32.5) 37 (48.7) 0.025 
Table 5. Comparison of the demographic data and the prevalence of the coronary heart 
disease risk factors and of absence of any of these risk factors between the coronary heart 
disease-present and -absent groups in the total study population 
 
 
Coronary Heart Disease
Present (n = 85) 
Coronary Heart Disease 
Absent (n = 30) 
 
p 
Moderate or severe aortic 
stenosis 
 
26 (30.6) 
 
6 (17.0) 
 
0.381 
Moderate or severe aortic 
regurgitation 
 
28 (32.9) 
 
7 (23.3) 
 
0.452 
Moderate or severe aortic 
stenosis or regurgitation 
 
57 (67.1) 
 
14 (46.7) 
 
0.079 
Aortic dilatation 37 (43.5) 10 (33.3) 0.447 
Table 6. Comparison of coronary heart disease-present and -absent subgroups of the 
bicuspid aortic valve disease group by the presence of moderate or severe aortic stenosis, 
moderate or severe aortic regurgitation, moderate or severe aortic stenosis or aortic 
regurgitation, and aortic dilatation 
3.6 Comparison of the prevalence rates of coronary heart disease within subgroups 
which were divided according to the type of bicuspid aortic valve 
None of the comparisons of the prevalence rates of coronary heart disease within subgroups 
which were divided according to the type of bicuspid aortic valve among 90 bicuspid aortic 
valve disease patients showed a significant difference (Table 7). 
 
 Coronary Heart Disease- 
Present (n = 66) 
Coronary Heart Disease- 
Absent (n = 24) 
 
p 
Type 1 54 (81.8) 16 (66.7) N.S. 
Type 2 12 (18.2) 6 (25.0) N.S. 
Type 3 0 (0.0) 2 (8.3) N.S. 
Table 7. Comparison of the prevalence rates of coronary heart disease within subgroups 
which were divided according to the type of bicuspid aortic valve. N.S.: Not significant 
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4. Discussion 
In the present study, in a specific population consisting of patients who underwent coronary 
angiography for suspected coronary heart disease (i.e., a population in which the incidence 
of coronary heart disease is expected to be high), we found a significantly higher prevalence 
of coronary heart disease in those patients with bicuspid aortic valve disease than in their 
age- and gender-matched counterparts without bicuspid aortic valve disease (73.9% vs. 
60.0%). The indices of angiographic severity and extent of coronary heart disease were also 
significantly higher in the bicuspid aortic valve disease group than in the control group. 
As mentioned earlier, there have been some case reports describing patients with bicuspid 
aortic valve disease associated with coronary atherosclerosis (Shimuzu et al., 1984; Bensaid 
et al., 1978; Yokoyama et al., 2002; Theleman et al., 2006) and even with acute myocardial 
infarction (Demir, 2009). However, to the best of our knowledge, there are only two studies 
in which the frequency of angiographic coronary heart disease has been given for patients 
with bicuspid aortic valve disease (Yuan et al., 2010; Goland et al., 2007). In one of these 
studies (Goland et al., 2007), which included 252 bicuspid aortic valve disease patients 
(mean age: 61 ± 15, 66.3% male) undergoing aortic valve replacement, the prevalence of 
coronary heart disease was 40.5%. In the other study (Yuan et al., 2010), the prevalence of 
angiographic coronary heart disease was not significantly different between the group 
consisting of the patients with bicuspid aortic valve disease who underwent cardiac surgery 
(n = 241), and the control group consisting 225 patients without bicuspid aortic valve disease 
who underwent an operation for an isolated aortic dilation, a combined aortic dilation and 
aortic valve abnormality, coarctation of the aorta, Marfan’s syndrome, aortic dissection, 
infective endocarditis, or aortic valve disorders (22.82% vs. 28.9%; p = not significant). 
However, that study was not designed primarily to compare the frequency of coronary 
heart disease in bicuspid aortic valve disease patients with that in an age- and gender-
matched control group. Accordingly, there were significant differences between these two 
groups, mainly with regard to mean age (56.1 ± 15.1 vs. 62.8 ± 14.7; p < 0.0001) and gender 
distribution (male/female: 3.38/1 vs. 1.78/1). To our knowledge, the present study is 
unique in prospectively examining the relationship between the presence of bicuspid aortic 
valve disease and the occurrence, severity, and extent of angiographic coronary heart 
disease. According to our knowledge, neither the above-mentioned two studies (Yuan et al., 
2010; Goland et al., 2007) nor the five case reports (Shimuzu et al., 1984; Bensaid et al., 1978; 
Yokoyama et al., 2002; Theleman et al., 2006; Demir, 2009) nor any other publication in the 
literature have suggested any explanation for a possible association between bicuspid aortic 
valve disease and coronary heart disease. 
First, it must be emphasized that since both of these diseases have high prevalences, there is 
a great possibility that their coexistence is not uncommon. Moreover, in some of the above-
mentioned reported cases, in addition to bicuspid aortic valve disease and coronary heart 
disease, a third disorder, which may be relevant to coronary heart disease, namely 
rheumatoid arthritis in one case (Shimuzu et al., 1984) and mitral annular calcification in an 
another case (Theleman et al., 2006), was also present. 
On the other hand, two possible explanations for the coexistence of the aforementioned 
congenital vascular abnormalities with bicuspid aortic valve disease or for long-term 
complications of bicuspid aortic valve disease have been proposed: (1) they may be 
secondary to flow dynamics (e.g., post-stenotic dilatation), and (2) there may be a common 
underlying developmental defect involving the aortic valve and the arterial wall (Niwa et 
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al., 2001; Bonderman et al., 1999; Hahn et al., 1992; Pachulski et al., 1991). In favor of the 
latter mechanism, the ascending aorta above a bicuspid aortic valve was reported to be 
dilated, irrespective of the presence or absence of aortic stenosis or regurgitation (Hahn et 
al., 1992; Pachulski et al., 1991). Moreover, the study by Niwa et al. (2001) reported that light 
and electron microscopic abnormalities in the tunica media of the ascending aorta above a 
bicuspid aortic valve were also identical irrespective of the functional state of the valve. The 
authors concluded that this observation was in favor of the view that there is an inherent 
fault in the ascending aortic media. Accordingly, we believe that similar mechanisms may 
also have been involved in our finding that the presence of bicuspid aortic valve disease is 
associated with the occurrence, severity, and extent of coronary heart disease. In favor of the 
former of the above two mechanisms, we observed trends toward an increased frequency of 
patients with moderate or severe aortic stenosis, aortic regurgitation, aortic stenosis or aortic 
regurgitation, and aortic dilatation in the coronary heart disease-present subgroup of the 
bicuspid aortic valve disease group. However, none of these differences were significant, 
perhaps because of the limited size of the study population. 
Of interest is that in some earlier papers it was suggested that more than 50% of patients 
with coronary heart disease lacked any of the aforementioned four conventional risk factors 
for atherosclerosis (Futterman & Lemberg, 1998; Hennekens, 1998). However, in some more 
recent studies, this percentage was reported to be between 15 and 20 (Khot et al., 2003; 
Greenland et al., 2003). In the present study, the percentage of patients without any of these 
risk factors was 27.1% in the coronary heart disease-present subgroup of the bicuspid aortic 
valve disease group and 39.1% in the coronary heart disease-present subgroup of control 
group (data not shown). Atherosclerosis, the major underlying cause of coronary heart 
disease, is present in all humans at an advanced age, and it progresses over a lifetime, but its 
extent and progression is dependent on its risk factors (Berenson et al., 1998). In addition, 
genetic factors are important. Twin studies indicate that the heritability of coronary heart 
disease, defined as the proportion of the interindividual differences resulting from genetic 
factors, is 30% to 60% (Marenberg et al., 1994). Existing research into the genetic basis of 
coronary heart disease falls into two categories. Firstly, earlier studies investigated 
candidate genes on which suspicion fell as result of evidence that the gene influenced one of 
the mechanisms by which coronary heart disease arose, such as lipoprotein metabolism or 
inflammation. More recently, genome-wide association studies have investigated many 
variants across the genome, without any underlying hypotheses. With the availability of 
high-density genome-wide association studies, and as studies become larger and more 
numerous, significant positive findings are emerging. These studies have resulted in the 
identification of 17 loci associated with coronary heart disease (reviewed in Sivapalaratnam 
et al., 2011). Still, only part of the heritability of coronary heart disease is currently 
explained. Accordingly, it can be also stated that there is a possibility for a common genetic 
basis for the association between bicuspid aortic valve disease and coronary heart disease. 
It is interesting that degenerative-calcific aortic stenosis, which predominantly affects older 
people, is a presentation of atherosclerosis (Faggiano et al., 2011; Otto et al., 1999; Branch et 
al., 2002). However, according to our knowledge, there are no studies in the literature 
reporting such an association for aortic stenosis of rheumatic origin or due to bicuspid 
valves and for aortic regurgitation or aortic dilatation of any origin. 
Among the findings of this study was the lack of independent predictiveness of the five 
conventional risk factors for coronary heart disease, namely hypercholesterolemia, 
hypertension, diabetes mellitus, cigarette smoking, and a family history of premature 
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coronary heart disease. Accordingly, none of these five risk factors was significantly 
different between the coronary heart disease-present and -absent groups in the total study 
population, although a trend toward a higher prevalence of hypertension, diabetes, and 
hypercholesterolemia in the former group was observed. We believe that these findings may 
probably be partly due to the relatively high prevalence of patients who were using 
medications against these risk factors (i.e., antihypertensive, antidiabetic, and lipid-lowering 
drugs). 
Finally, it should be also stated that, our findings that the increased prevalence of left 
dominance (Hutchins et al., 1975; Higgins & Wexler, 1975) and significantly shorter left 
main coronary artery length (Hutchins et al., 1975; Higgins & Wexler, 1975; Yuan et al., 
2010) in patients with bicuspid aortic valve disease are in general in accord with the studies 
in the literature. 
5. Limitations of the study 
Because it is unethical to do coronary angiography on every patient with bicuspid aortic 
valve disease, the study was done on patients who underwent coronary angiography for 
suspected coronary heart disease (i.e., on patients in whom the probability of coronary heart 
disease was high). It is clear that this is not an ideal design to investigate a probable 
relationship between bicuspid aortic valve disease and coronary heart disease. 
6. Conclusion 
In conclusion, there may be an association between bicuspid aortic valve disease and 
coronary heart disease. It is both possible that this association is due to structural changes in 
the walls of the coronary arteries secondary to flow dynamics in bicuspid aortic valve 
disease or to a common underlying congenital cause involving both the aortic valve and 
coronary arteries. It is also possible that both of these factors may make the coronary arteries 
prone to atherosclerosis. More studies are needed to confirm our findings and to study the 
potential mechanisms of this association. 
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